Black Diamond Therapeutics I
BDTX·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$1.89
Today
+0.5%
YTD
-21.6%
About
Black Diamond Therapeutics is a biotechnology company based in Cambridge, Massachusetts. The firm is engaged in the development of precision treatments for cancers and genetic diseases. Founded in 2014, the firm serves customers throughout the US and is listed on the NASDAQ GS with the ticker BDTX. Diversify your portfolio today by investing in BDTX stock on eToro.
Price chart
Closing price history for BDTX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-2.54
P/S (TTM)0.00
P/B (TTM)1.13
Market cap$108.59M
Cap tierMicro-cap
Industry avg P/E-2.03
Profitability
Gross margin99.54%
EBIT margin0.00%
Net margin80.77%
ROE-37.21%
ROA-29.21%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)-100.0%
EPS (TTM)-$0.74
Free cash flow$-32.84M
Total debt$16.97M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.74
Employees21
Next earnings5 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.